US20090178932A1 - Control of biocatalysis reactions - Google Patents
Control of biocatalysis reactions Download PDFInfo
- Publication number
- US20090178932A1 US20090178932A1 US12/414,506 US41450609A US2009178932A1 US 20090178932 A1 US20090178932 A1 US 20090178932A1 US 41450609 A US41450609 A US 41450609A US 2009178932 A1 US2009178932 A1 US 2009178932A1
- Authority
- US
- United States
- Prior art keywords
- reaction mixture
- process according
- reaction
- membrane
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 71
- 239000011541 reaction mixture Substances 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 51
- 230000008569 process Effects 0.000 claims abstract description 40
- 230000005684 electric field Effects 0.000 claims abstract description 25
- 239000012528 membrane Substances 0.000 claims description 76
- 230000036983 biotransformation Effects 0.000 claims description 30
- 238000000909 electrodialysis Methods 0.000 claims description 25
- 150000001450 anions Chemical class 0.000 claims description 23
- 238000000926 separation method Methods 0.000 claims description 21
- 239000000872 buffer Substances 0.000 claims description 20
- 241000894006 Bacteria Species 0.000 claims description 13
- 238000000855 fermentation Methods 0.000 claims description 12
- 230000004151 fermentation Effects 0.000 claims description 12
- 125000002091 cationic group Chemical group 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 238000009629 microbiological culture Methods 0.000 claims description 8
- 125000000129 anionic group Chemical group 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 239000011324 bead Substances 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 4
- 239000011148 porous material Substances 0.000 claims description 4
- 239000003014 ion exchange membrane Substances 0.000 claims 2
- 238000004590 computer program Methods 0.000 claims 1
- 230000000284 resting effect Effects 0.000 claims 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 74
- 239000000047 product Substances 0.000 description 69
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 51
- 210000004027 cell Anatomy 0.000 description 41
- 239000005711 Benzoic acid Substances 0.000 description 33
- 235000010233 benzoic acid Nutrition 0.000 description 33
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 24
- 230000000694 effects Effects 0.000 description 23
- 239000004310 lactic acid Substances 0.000 description 23
- 235000014655 lactic acid Nutrition 0.000 description 23
- 238000004519 manufacturing process Methods 0.000 description 23
- 238000007792 addition Methods 0.000 description 18
- 239000012141 concentrate Substances 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 239000002028 Biomass Substances 0.000 description 10
- 239000011521 glass Substances 0.000 description 10
- 238000013461 design Methods 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 230000005012 migration Effects 0.000 description 7
- 238000013508 migration Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000007853 buffer solution Substances 0.000 description 6
- 238000011027 product recovery Methods 0.000 description 6
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 229940072056 alginate Drugs 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000002860 competitive effect Effects 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000009285 membrane fouling Methods 0.000 description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108090000913 Nitrate Reductases Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000002210 biocatalytic effect Effects 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 231100000481 chemical toxicant Toxicity 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- -1 organic acid anions Chemical class 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- MLONYBFKXHEPCD-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(N)(CO)CO.OCC(N)(CO)CO MLONYBFKXHEPCD-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 229920000557 Nafion® Polymers 0.000 description 1
- 229920005439 Perspex® Polymers 0.000 description 1
- 241000187693 Rhodococcus rhodochrous Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000003011 anion exchange membrane Substances 0.000 description 1
- 239000012431 aqueous reaction media Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000011138 biotechnological process Methods 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000000332 continued effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- HTXDPTMKBJXEOW-UHFFFAOYSA-N dioxoiridium Chemical compound O=[Ir]=O HTXDPTMKBJXEOW-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000003411 electrode reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229910001448 ferrous ion Inorganic materials 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910000457 iridium oxide Inorganic materials 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000000409 membrane extraction Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 230000035409 positive regulation of cell proliferation Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004590 silicone sealant Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 229910001936 tantalum oxide Inorganic materials 0.000 description 1
- 239000010891 toxic waste Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/56—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B3/00—Electrolytic production of organic compounds
Definitions
- the present invention is concerned with controlling biocatalysis reactions, and particularly with controlling the rate of such reactions so as to optimise the yield of bioproducts derived therefrom.
- Bioconversion processes are becoming increasingly important to the manufacture of high added value chemical intermediates such as pharmaceuticals, flavours and fragrances, and the like. As a result, bioconversion processes are increasingly being used to replace traditional fine chemicals manufacturing techniques which often require the use of organic solvents and the addition of chemical reagents, which create toxic waste streams requiring expensive treatment to protect the environment. Such chemical processes are also hazardous and energy intensive, since they are operated at high temperatures and pressures.
- Bioprocesses also offer extensive possibilities for synthetic routes to organic compounds, which are often difficult to prepare by established chemical methods.
- the application of biological systems to chemicals manufacturing offers several advantages: high selectivity, with enzymes distinguishing between enantiomers and regio-isomers; use of aqueous reaction media and operation under near-ambient conditions.
- Biocatalysis offers considerable advantages over traditional processing methods being an intrinsically clean technology which avoids the necessity to add significant quantities of toxic chemicals, while being carried out under ambient pressures and low temperatures.
- Electroporation has been studied previously in the field of the interactions between electrical fields and living cells.
- the technique is usually associated with reversible cell membrane permeabilisation, resulting from the application of high voltage electrical fields (about 1600 volts) for short periods (0.1 to 10 milliseconds) as opposed to cell inactivation due to membrane breakdown under the influence of strong fields.
- high voltage electrical fields about 1600 volts
- short periods 0.1 to 10 milliseconds
- it is thought to function by virtue of the elevated transmembrane potential difference which leads to membrane structural rearrangements such that aqueous pathways or pores occur, thereby facilitating mass transfer processes.
- the influence of electric field pulses can greatly enhance the molecular transport through cell membranes, for example the electro-uptake of high molecular weight molecules to which cell membranes would normally be impermeable.
- electroporation The most important application of electroporation is the direct transfer of DNA into recipient cells of different origin (electrotransformation), while electrorelease is the use of strong electric field pulses to induce the release of cell ingredients e.g., to obtain intracellular proteins.
- electroporative transfer of molecules (other than DNA), into recipient cells can also be achieved by electric fields. Examples of such molecules include proteins, antibodies, drugs, mutagens, and substances to which the cell membrane is poorly permeable or non-permeable.
- Another general area of interest involves the effects of electric fields on cell growth and metabolite production.
- stimulation of cell proliferation by direct current has been studied.
- these have involved the transfer of chemicals produced by the electrode reaction to the cell enzymes, e.g., oxygen, hydrogen, ferrous ion, co-enzymes.
- An example is the use of electrolytically generated hydrogen as an electron donor for the hydrogenase enzyme to catalyse the reduction of precious metal ions to the metallic element (3).
- the present inventors have now surprisingly found that when a DC electrical field is applied to a reaction mixture, biotransformation reactions can be increased under the influence of the electrical field when the reaction mixture is maintained or disposed separately from the means used to apply the field, such that it is not brought into contact therewith.
- a process for increasing the rate of biocatalysis reactions which comprises applying a direct current electric field to a reaction mixture, wherein the reaction mixture and the means to deliver said electric field are separated such that the reaction mixture does not come into contact with said electric field delivery means.
- the electrical field may be applied using techniques that are well known to the skilled practitioner, such as by the use of electrodes or the like in an electrochemical reactor.
- the enhancement in the rate of bioprocesses occurring in the reaction mixture results in increased turnover frequency (number of converted molecules per unit of time), decreased residence time (ratio of reactor volume to feed rate) and increased space-time yield (mass of product synthesised per reactor volume and time).
- reaction mixture which may include biological organisms, such as microorganisms
- the effect is stimulatory.
- each electrode is maintained in a glass tube having a porous window and containing an inert electrolyte, and which allows the passage of current to the bioreaction mixture but prevents any biomass in the mixture from contacting the electrodes.
- the present invention can also be utilised in combination with modified electrodialysis to realise the continued effects of increased reaction rates with product separation and concentration.
- Significantly improved performance can be achieved in the process by utilising electrodialysis, particularly during extraction of products, for example from live biotransformation reactions, but also for batch treatment upon completion of the reaction.
- the electrodes form part of an electrochemical reactor, within which the reaction mixture is maintained, and which reactor includes a suitable electrodialysis membrane.
- a further potential benefit provided by the use of an electrodialysis membrane such as a bipolar membrane is the continuous extraction and concentration of charged ionic organic products from live biocatalysis reactions.
- the approach would avoid the need to kill organisms on a routine basis, as required with an intermittent operational regime, and would provide the opportunity to maintain biocatalysis reactions under optimum pH conditions on a continuous operational basis. Reduced process costs would result from higher throughput rates and lower capital requirements, as well as lower consumption of chemicals and biocatalysts/biomass. Since the product would be maintained at a low concentration in the bioreaction mixture, any negative feedback inhibition of the biocatalysis process (e.g., observed in lactic acid fermentation reactions) would be avoided. In addition, the product would be recovered at much higher concentrations using electrodialysis membranes than could be produced directly in the biocatalysis reaction mixture which would improve the efficient isolation of pure product.
- anion selective membranes in addition to separating the reaction mixture from the electrodes, can also serve to transport organic acid anions through anion selective membranes from the bioreaction mixture through to a product stream.
- a cationic buffer system into the reaction mixture, in place of standard anionic buffer systems.
- the pH can be controlled automatically by adjusting the applied DC current, reducing the need for pH control by the addition of chemicals. It was observed that back-diffusion of product (e.g., lactic acid) was observed when the current was switched off. Therefore, at least a small residual current should be maintained in cases where a significant period without applied current would allow back-diffusion to occur.
- a typical cationic buffer system is “bis-Tris” Bis(2-hydroxyethyl)-imino-tris(hydroxymethyl)methane.
- a further feature of the invention which is enabled by the use of a cationic buffer system, is therefore the development of pH control without the addition of chemicals, by adjustment of the applied DC current.
- the pH control can be accomplished preferably by for example a computer-controlled current regulation system.
- the pH falls as a result of the production of acidic product (e.g., benzoic acid, lactic acid, etc.).
- acidic product e.g., benzoic acid, lactic acid, etc.
- addition of base is necessary throughout to maintain the pH of the reaction mixture within the range necessary.
- Continuous membrane extraction of the organic anion enables the replacement and neutralisation of the acid product by hydroxyl ion produced in the bipolar membrane by water splitting.
- a standard anionic buffer system is being used in the separation system, the buffer is progressively displaced and pH control cannot be maintained. This problem has been overcome through the incorporation of a cationic buffer system which enables the pH to be controlled by the level of applied DC current through the membrane stack.
- Examples 6 and 8 are abiotic experiments in which the product benzoic acid (Example 6) or lactic acid (Example 8) is added to the reaction mixture to simulate its production in a fermentation process. This demonstrates this effect by matching the applied current to the addition rate of benzoic acid or lactic acid, and indicates that the product (benzoic acid or lactic acid) migration rate is linearly dependent on the applied current density.
- a general advantage of electrochemical processes is therefore that automatic control can be readily effected, since it is possible to control the reaction rate by adjustment of the applied current.
- An aspect of this invention is the development of automatic pH control of biotransformation reaction mixtures, as part of continuous product recovery by modified electrodialysis.
- a useful, novel aspect of the present invention concerns the combination of the bio-reactor with the electro-membrane separation/concentration into a single integrated system, since the advantages of both the DC enhancement effect reaction rate and the improved electrodialysis product recovery system can be realised.
- the bio-reactor can be situated within an electrodialysis cell (as shown in FIG. 2 ) or the biomass can be contained mainly in a separate bio-reactor and re-circulated to an electrodialysis stack (as shown in FIG. 3 ).
- the current literature on the integration of electrodialysis processes with biocatalysis does not describe any interaction between the electric field and the biological material.
- the improvements across the electrodialysis process will provide more efficient, continuous operation of biocatalysis reactions.
- the solutions offered by the invention advantageously will allow bipolar electrodialysis to be applied to continuous extraction of ionic organic products from live biocatalysis reaction mixtures thus preventing competitive anion transfer resulting in the substantial increase in the current efficiency of the product separation process.
- the invention will enable control of the pH within the narrow optimal range essential for efficient operation of each specific biocatalysis reaction. Manual adjustment of the current supply has been suggested by prior workers as a method of controlling pH in lactic acid production by fermentation (9). However, imbalances in the system due to the transport of inorganic components in the fermentation broth were not taken into account. The improvements proposed will allow precise continuous control of pH.
- the improvements in product separation/concentration offered by the invention can be applied to a broad spectrum of biocatalysis processes which involve the production of acidic organic compounds which are dissociated into negatively charged anions within the pH range necessary for high enzymatic activity.
- the approach has been applied to two specific reactions as set out more fully below, which are examples of two generic reaction types. Firstly, a whole cell single enzyme biotransformation, i.e., the conversion of benzonitrile to benzoic acid by Rhodococcus rhodochrous LL100-21. Secondly, a whole cell multi-enzyme step fermentation, i.e., lactic acid production from glucose by Lactobacillus rhamnosus NCIMB 6375.
- the specific arrangements of the membranes according to the preferred aspects of the invention are provided in FIGS. 2 to 4 .
- the bio-reaction mixture is contained between an anion-selective membrane on the anode-facing side and a bipolar membrane on the cathode facing side.
- anionic components e.g., borate
- competition is observed between the transport of the buffer anion and the organic acid anion.
- the current efficiency for product transfer is relatively low, e.g., the average current efficiency for benzoate transport is only 50% in the presence of 0.045 M boric acid. Because of this process inefficiency, substantially higher energy is consumed in achieving the desired rate of removal of the organic product.
- Example 7 a current efficiency of 75% was observed.
- the example is an abiotic experiment in which the addition of benzoic acid to the reaction mixture simulates its production during a fermentation process. TRIS buffer was used for the simulated bio-reaction stream.
- the competitive charge transport by migration of hydroxide produced at the bipolar membrane decreases the current efficiency, however, this can be reduced by higher organic product concentrations.
- the low solubility of benzoic acid in water prevents its use for an example to prove this point.
- Example 8 the current efficiency observed was close to 100%, significantly reducing the energy consumption and also increasing the rate of product separation.
- the example is an abiotic experiment in which the addition of lactic acid to the reaction mixture simulates its production during a fermentation process. Also, the presence of the bipolar membrane prevents the transport of the cationic buffer (bis-Tris in this case) towards the cathode, so that the buffer is retained within the bio-reaction mixture. As a result, the pH can be closely maintained without the consumption of expensive chemicals.
- the present invention has solved this problem by the immobilisation of microorganisms used which advantageously prevents fouling of membranes.
- the present inventors have found that membrane fouling is therefore either prevented or at least greatly reduced by using immobilised microorganisms, for example yeasts or bacteria. This effect was observed during the experiment given in Example 4, where the immobilisation medium was incorporated into a combined bio/electrodialysis reactor in order to benefit from the effects of both the DC field enhancement and reduced membrane fouling.
- the volume of the electrodialysis stack reactor required to carry out this procedure in a combined bio/electrodialysis reactor would be very large.
- An alternative approach may be to contain the immobilisation media incorporating the microorganisms in a separate bioreactor of a standard design (continuously stirred, fluidised bed, packed bed, etc.).
- no DC enhancement effect would be obtained in that case, since the microorganisms would not be exposed to the field. Therefore, a second DC field would be required, which may be applied to the bioreactor containing the immobilised microorganism, in order to obtain the DC enhancement effect in addition to product recovery/concentration.
- the second system would incorporate two bipolar membranes either side of the reactor to enable the field effects to be achieved without separation (as in Example 3). A relatively small area of bipolar membrane would be necessary in the bio-reactor to achieve the enhancement effect, while the relatively high membrane area required for product separation would be provided in a separate membrane stack.
- the biocatalysis reaction according to the invention may comprise any of a single enzyme biotransformation reaction, a fermentation process, or a reaction catalysed by an isolated enzyme system.
- the reactions may be carried out with the assistance of growing microbial cultures, vesting microbial cultures or immobilised cultures of bacteria, fungi, or yeasts.
- FIG. 1 is an illustration of a glass reactor consisting of a round-bottomed glass vessel with flanged lid.
- the Bio-Reaction Chamber ( 3 ) includes a spherical reaction vessel with total capacity of 250 ml.
- the Anode ( 1 ) and the Cathode ( 2 ) are housed in glass tubes, inserted through the flanged lid and contained in inert electrolyte.
- the electrodes are made of platinised titanium, with a rectangular surface of 2 cm ⁇ 1.5 cm.
- the tubes are immersed in the biotransformation reaction mixture contained within the flask.
- the reaction mixture is separated from the anode and cathode compartments by Porous Glass Windows ( 4 ).
- the separators allow the passage of current, but prevent the biomass from contacting the electrodes. No product separation was involved.
- FIG. 2 is an illustration of a combined Bio-/Electro-Membrane Reaction used in the present invention.
- This reactor design enables the Bio-reactor chamber to be integrated within a modified electrodialysis stack containing ion selective and biopolar membranes, so that the effects of biotransformation reaction rate enhancement and product separation can be combined.
- the reactor contains a Bio-Reaction Chamber ( 3 ) made of Perspex with a 1.4 L working capacity, containing the entire volume of the biotransformation reaction mixture.
- a magnetic stirrer continuously mixes the medium containing the cell mass in the central chamber, but there is no circulation of this mixture to an external vessel.
- Bolted onto one side are two further chambers and the Anode ( 1 ) (platinised titanium).
- An Anion Selective Membrane ( 5 ) (Neosepta ACM) is situated between the Bio-Reaction Chamber and the Product Concentrate Chamber ( 8 ).
- the product chamber is separated from the Anolyte Chamber ( 9 ) by a cation selective membrane ( 7 ) (DuPont Nafion 450).
- a Bipolar Membrane ( 6 ) (Tokuyama Co. Ltd. BPM 1) separates the Bio-Reaction Chamber and the catholyte chamber. Chambers ( 8 ), ( 9 ) and ( 10 ) are much thinner than chamber ( 3 ) and are fitted with inlets and outlets to enable the solutions to be circulated to separate external reservoirs at the speed of 20 ml/min.
- the electrodes of the reactor have a rectangular surface of 10 cm ⁇ 10 cm.
- FIG. 3 is an illustration of an Electro-Membrane Stack Reactor used in accordance with the present invention.
- the reactor design enables a generic, industrial electro-membrane stack system to be used for the enhancement of bio-transformation reaction rate and separation of product.
- the reaction mixture, containing biomass, is re-circulated from a separate bio-reactor, through the Bio-Reaction Chamber of the membrane stack reactor.
- the stack contains four chambers fabricated from HDPE with dimensions 3 mm ⁇ 160 mm ⁇ 230 mm.
- the active area of each membrane exposed by the frames was 120 mm ⁇ 160 mm.
- a polymer mesh (HDPE) is provided in each frame to provide membrane support and good hydrodynamic flow.
- the Bio-Reaction Chamber dimensions are identical to the other chambers. All solutions are re-circulated to external vessels. In the case of the reaction mixture, the biomass is in suspension and therefore passes through the electro-membrane stack and is exposed to the DC field for part of the time.
- the two end plates incorporate recessed electrodes.
- the anode tantalum/iridium oxide coated titanium
- a bead of Silicone Sealant which fills an annular groove machined in the electrode recess PVC plate.
- the cathode titanium is similarly sealed into the PVC support plate.
- the electrodes have a rectangular surface of 120 mm ⁇ 160 mm.
- Electrodes and membranes are identical to that described in the Combined Bio-/Electro-Membrane Reactor (component numbering is the same).
- FIG. 4 is an illustration of Membrane Arrangements used in Single and Multiple Unit Stacks.
- FIG. 4 The arrangement of membranes used in the Electro-Membrane Stack Reactor is given in FIG. 4 .
- the system contains a single unit of one bipolar membrane and one anion selective membrane, with a single cation selective membrane adjacent to the anolyte compartment.
- FIG. 4( b ) illustrates the arrangement used in a multiple unit cell for industrial application.
- the experiment was repeated under the same conditions without applying a constant electric current to the cells in the glass cell reactor.
- the average production rate in the absence of electric current was 0.020 mmol/min/g dcw.
- the pH of the product concentrate was maintained at pH 8 through addition of 4 N NaOH by means of a pH control system comprising a DIN rail mounted pH controller, a variable pump, and a pH electrode.
- a pH control system comprising a DIN rail mounted pH controller, a variable pump, and a pH electrode.
- 500 ml of TBB was used as electrolyte for chambers ( 8 ), ( 9 ), and ( 10 ).
- the experiment was repeated under the same conditions without applying a constant electric current to the cells in the electrokinetic reactor.
- the average production rate in the absence of electric current was 0.031 mmol/min/g dcw.
- This example shows that electric current increases the biotransformation rate by 42% and that concentrated benzoic acid can be recovered by electrodialysis.
- this reactor was modified by replacing the anion selective membrane (used in Example 2) between the Bio-Reaction Chamber and the Product Concentrate Chamber by a bipolar membrane (Tokuyama Neosepta BP-1), therefore no benzoic acid product was transported out of the reaction mixture.
- 10 mM of benzonitrile was added to the cells and DC current was switched on (16.6 A/m 2 ).
- the average production rate was 0.023 mmol/min/g dcw.
- the experiment was repeated under the same conditions without applying a constant electric current to the cells in the reactor.
- the average production rate in the absence of electric current was 0.018 mmol/min/g dcw. This example shows that electric current stimulates bacterial metabolism increasing the biotransformation rate by 28%.
- the biotransformation rate was 0.030 mmol/min/g dcw. After 210 min 10 mM of benzonitrile was added again and DC current was switched on (16.6 A/m 2 ). In the presence of the constant electric current the average production rate was 0.044 mmol/min/g dcw. Benzoic acid migrated into the Product Concentrate Chamber with a migration rate of 0.02 mmol/min. This example shows that electric current increases the biotransformation rate by 47% and that concurrent separation and concentration of benzoic acid can be achieved with this electro-membrane stack.
- Benzoic acid was first added with an addition rate of 0.025 mmol/min. The supplied current was 0.09 A. After 41 ⁇ 2 hours the addition rate was decreased to 0.012 mmol/min and the current was changed to 0.04 A. Half an hour afterwards benzoic acid was added with a rate of 0.041 mmol/min and the current was changed to 0.15 A. After 51 ⁇ 2 hours operation 20 mmol of benzoic acid (82% of the total benzoic acid) were recovered in the Product Concentrate stream. 4 mmol of benzoic acid remained in the Bio-Reaction stream (16% of the total benzoic acid). The average current efficiency was 50%. During the experiment the pH in the Bio-Reaction stream stayed between 8.0 and 8.1.
- This example shows that the pH in the reaction mixture can be controlled by adjustment of the applied current and that the migration rate of the product (benzoic acid in this case) is linearly dependent on the applied current density.
- a solution (0.5 litre) of 0.05 M bis-Tris buffer containing 0.1 mol lactic acid was circulated through the Bio-Reaction Chamber.
- DC current was supplied to the stack.
- Lactic acid (85%) was added continuously to the solution circulated through the Bio-Reaction Chamber with varying addition rates.
- the current to be applied was changed manually according to the lactic acid addition rate to maintain the pH at 6.
- Lactic acid was first added with an addition rate of 2.4 mmol/min for 4 hours.
- the supplied current was 3.5 A. After 4 hours the addition rate was increased to 3.6 mmol/min and the current was changed to 5.2 A. 11 ⁇ 2 hours afterwards lactic acid was added with a rate of 4.8 mmol/min and the current was changed to 6.9 A.
- Example 2 the product (benzoic acid) was also transferred continuously from the biotransformation reaction mixture by the DC field through an anion selective membrane into a product stream.
- Example 3 the anion membrane was replaced by a bipoloar membrane, so that no transfer of product was possible.
- separation of product (as carried out in Example 2) was combined with immobilisation of the bacterial cells on alginate beads.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Metallurgy (AREA)
- Materials Engineering (AREA)
- Electrochemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
A process for increasing the rate of biocatalysis reactions, which comprises applying a direct current electric field to a reaction mixture, wherein the reaction mixture and the electrodes used to apply said electric field are separated such that the reaction mixture does not come into contact with said electrodes.
Description
- This application is a continuation of U.S. patent Ser. No. 10/535,687, filed May 19, 2005, which is the national phase of PCT/GB2003/005031, filed Nov. 19, 2003, which claims foreign priority to GB 0227021.3, filed Nov. 19, 2002, which are all herein incorporated by reference.
- 1. Field of the Invention
- The present invention is concerned with controlling biocatalysis reactions, and particularly with controlling the rate of such reactions so as to optimise the yield of bioproducts derived therefrom.
- Bioconversion processes are becoming increasingly important to the manufacture of high added value chemical intermediates such as pharmaceuticals, flavours and fragrances, and the like. As a result, bioconversion processes are increasingly being used to replace traditional fine chemicals manufacturing techniques which often require the use of organic solvents and the addition of chemical reagents, which create toxic waste streams requiring expensive treatment to protect the environment. Such chemical processes are also hazardous and energy intensive, since they are operated at high temperatures and pressures.
- Bioprocesses also offer extensive possibilities for synthetic routes to organic compounds, which are often difficult to prepare by established chemical methods. The application of biological systems to chemicals manufacturing offers several advantages: high selectivity, with enzymes distinguishing between enantiomers and regio-isomers; use of aqueous reaction media and operation under near-ambient conditions.
- Biocatalysis, therefore, offers considerable advantages over traditional processing methods being an intrinsically clean technology which avoids the necessity to add significant quantities of toxic chemicals, while being carried out under ambient pressures and low temperatures.
- An important generic factor to be considered during process design and operation is process intensification. High throughput rates are important for cost reduction in terms of capital utilisation and operational costs. Achieving increased reaction rates in biocatalytic processes is therefore a desirable goal.
- The rates of biocatalytic processes are limited by numerous factors. For example, the relevant enzymes in the vast majority of whole cell biocatalysis reactions are retained within the cells. Reactions will only occur at a significant rate if the organic chemical substrate has good access to the enzyme complement of the cell, and if the product can be easily recovered from the cell. Developing new methods, which are able to overcome the factors limiting reaction rates, could result in significant potential economic benefits to manufacturing industry.
- Biocatalysis therefore offers considerable advantages over traditional processing methods being an intrinsically clean technology, which avoids the necessity to add significant quantities of toxic chemicals, while being carried out under ambient pressures and at low temperatures.
- Electroporation has been studied previously in the field of the interactions between electrical fields and living cells. The technique is usually associated with reversible cell membrane permeabilisation, resulting from the application of high voltage electrical fields (about 1600 volts) for short periods (0.1 to 10 milliseconds) as opposed to cell inactivation due to membrane breakdown under the influence of strong fields. In general, it is thought to function by virtue of the elevated transmembrane potential difference which leads to membrane structural rearrangements such that aqueous pathways or pores occur, thereby facilitating mass transfer processes. The influence of electric field pulses can greatly enhance the molecular transport through cell membranes, for example the electro-uptake of high molecular weight molecules to which cell membranes would normally be impermeable. The most important application of electroporation is the direct transfer of DNA into recipient cells of different origin (electrotransformation), while electrorelease is the use of strong electric field pulses to induce the release of cell ingredients e.g., to obtain intracellular proteins. The electroporative transfer of molecules (other than DNA), into recipient cells can also be achieved by electric fields. Examples of such molecules include proteins, antibodies, drugs, mutagens, and substances to which the cell membrane is poorly permeable or non-permeable.
- The use of the technique in biotechnology has also been considered. Velizarov et al. (1999) (1) stated that electroporation might also be applied to improve substrate utilisation efficiency in some biotechnological processes. An example given is the use of AC electric pulses of 0.25 kV for 10 ms to treat a yeast strain to enhance cellobiose utilisation and conversion to ethanol. In McCabe et al. (1995) ethanol production was found to increase by almost 40% above that found in fermentations containing non-treated cells (2). In these examples, electroporation is achieved using AC fields.
- Another general area of interest involves the effects of electric fields on cell growth and metabolite production. In this topic area, stimulation of cell proliferation by direct current has been studied. Generally, these have involved the transfer of chemicals produced by the electrode reaction to the cell enzymes, e.g., oxygen, hydrogen, ferrous ion, co-enzymes. An example is the use of electrolytically generated hydrogen as an electron donor for the hydrogenase enzyme to catalyse the reduction of precious metal ions to the metallic element (3).
- The influence of pulsed electromagnetically induced currents, using devices such as pairs of Helmholtz coils, on processes in biotechnology has also been studied. Hones et al. (1998) refer to an anaerobic bacterium expressing the enzyme nitrate reductase, which returns nitrogen to the atmosphere by denitrification. A low frequency alternating field induction in the mTorr range was used to give evidence of the possibility of accelerating cellular reactions. The authors state that the possible consequences for such fermentations are either the significant increase of biomass yield or an increase in the rate of fermentation. It was concluded that the pulsed electric field accelerates the cell division process, not the turnover number of the nitrate reductase.
- The present inventors have now surprisingly found that when a DC electrical field is applied to a reaction mixture, biotransformation reactions can be increased under the influence of the electrical field when the reaction mixture is maintained or disposed separately from the means used to apply the field, such that it is not brought into contact therewith.
- Therefore, according to a first aspect of the present invention, there is provided a process for increasing the rate of biocatalysis reactions, which comprises applying a direct current electric field to a reaction mixture, wherein the reaction mixture and the means to deliver said electric field are separated such that the reaction mixture does not come into contact with said electric field delivery means. The electrical field may be applied using techniques that are well known to the skilled practitioner, such as by the use of electrodes or the like in an electrochemical reactor. Advantageously, the enhancement in the rate of bioprocesses occurring in the reaction mixture results in increased turnover frequency (number of converted molecules per unit of time), decreased residence time (ratio of reactor volume to feed rate) and increased space-time yield (mass of product synthesised per reactor volume and time). Although the mechanistic pathways by which the enhancement effect is realised are currently unknown, because the electrodes are separated from the bioreaction mixture, no direct electron transport reactions can occur. Accordingly, the beneficial effect on bioreaction rate can only result from the influence of the DC electrical field. As set out more fully in the accompanying examples, the effect has been demonstrated to provide consistent rate improvements in specific biocatalysis reactions.
- Thus, when the reaction mixture, which may include biological organisms, such as microorganisms, are physically protected from the area surrounding the electrodes and subsequent contact with the electrodes the effect is stimulatory.
- A number of methods will be apparent to the skilled practitioner for maintaining the electrodes separate from the reaction mixture and yet which can transmit or apply the electrical field to the reaction mixture. For example, the electrodes may be provided in a glass or other suitable container within the reaction mixture. In one embodiment, as identified in
FIG. 1 , each electrode is maintained in a glass tube having a porous window and containing an inert electrolyte, and which allows the passage of current to the bioreaction mixture but prevents any biomass in the mixture from contacting the electrodes. - Advantageously, the present invention can also be utilised in combination with modified electrodialysis to realise the continued effects of increased reaction rates with product separation and concentration. Significantly improved performance can be achieved in the process by utilising electrodialysis, particularly during extraction of products, for example from live biotransformation reactions, but also for batch treatment upon completion of the reaction.
- The application of conventional electrodialysis methods, following completion of a batch biocatalysis reaction and removal of biomass by filtration of the mixture has been studied previously (5, 6). A variation of this technique is the use of bipolar membrane electrodialysis, which enables recovery of the product in a more purified form by separating the organic product from inorganic constituents (7), or preparation of an acid from a salt (8), again after completion of batch biotransformation reactions. Therefore, according to this aspect of the invention, the electrodes form part of an electrochemical reactor, within which the reaction mixture is maintained, and which reactor includes a suitable electrodialysis membrane.
- A further potential benefit provided by the use of an electrodialysis membrane such as a bipolar membrane is the continuous extraction and concentration of charged ionic organic products from live biocatalysis reactions. The approach would avoid the need to kill organisms on a routine basis, as required with an intermittent operational regime, and would provide the opportunity to maintain biocatalysis reactions under optimum pH conditions on a continuous operational basis. Reduced process costs would result from higher throughput rates and lower capital requirements, as well as lower consumption of chemicals and biocatalysts/biomass. Since the product would be maintained at a low concentration in the bioreaction mixture, any negative feedback inhibition of the biocatalysis process (e.g., observed in lactic acid fermentation reactions) would be avoided. In addition, the product would be recovered at much higher concentrations using electrodialysis membranes than could be produced directly in the biocatalysis reaction mixture which would improve the efficient isolation of pure product.
- A number of difficulties must be overcome in order to improve the efficiency and cost effectiveness of product recovery by bipolar membrane electrodialysis, either from batch or continuous systems. A large number of ionic organic products are negatively charged at the pH levels necessary for biocatalysis reactions, e.g., carboxylates, and can be extracted from a reaction mixture through anion selective membranes. However, there are normally other components in the reaction mixture, which are also negatively charged, and will tend to move through the membrane, competing with the product anions. This has three major disadvantages. Firstly, the current efficiency for product recovery is reduced as a result of competitive anion transfer and the power requirement costs are significantly increased. Secondly, the anionic components of standard buffers, which are normally used in biocatalysis reactions, are transported from the reaction mixture and, as a result, the pH cannot be precisely controlled within the narrow limits necessary for efficient biocatalysis. Thirdly, the product stream is contaminated by the other anions transported, which can affect the final product recovery stage.
- Thus, the anion selective membranes, as indicated more fully in the examples below, in addition to separating the reaction mixture from the electrodes, can also serve to transport organic acid anions through anion selective membranes from the bioreaction mixture through to a product stream.
- In a preferred embodiment of the invention there is incorporated a cationic buffer system into the reaction mixture, in place of standard anionic buffer systems. This advantageously results in a substantial increase in the efficiency of the product removal process. In addition, by preventing the loss of buffer, the pH can be controlled automatically by adjusting the applied DC current, reducing the need for pH control by the addition of chemicals. It was observed that back-diffusion of product (e.g., lactic acid) was observed when the current was switched off. Therefore, at least a small residual current should be maintained in cases where a significant period without applied current would allow back-diffusion to occur. A typical cationic buffer system is “bis-Tris” Bis(2-hydroxyethyl)-imino-tris(hydroxymethyl)methane.
- A further feature of the invention, which is enabled by the use of a cationic buffer system, is therefore the development of pH control without the addition of chemicals, by adjustment of the applied DC current. The pH control can be accomplished preferably by for example a computer-controlled current regulation system.
- As the biocatalysis reaction proceeds, the pH falls as a result of the production of acidic product (e.g., benzoic acid, lactic acid, etc.). In a batch process without continuous separation, addition of base is necessary throughout to maintain the pH of the reaction mixture within the range necessary. Continuous membrane extraction of the organic anion enables the replacement and neutralisation of the acid product by hydroxyl ion produced in the bipolar membrane by water splitting. However, if a standard anionic buffer system is being used in the separation system, the buffer is progressively displaced and pH control cannot be maintained. This problem has been overcome through the incorporation of a cationic buffer system which enables the pH to be controlled by the level of applied DC current through the membrane stack.
- For each product anion transferred through the anion selective membrane from the reaction mixture to the product stream, a hydroxyl ion is produced by the bipolar membrane due to the splitting of water, which neutralises the acid produced by the biocatalysis process. Since the transfer of organic product anion out of the reaction mixture is quantitative, due to the presence of the cationic buffer, no buffer is displaced and the system is in balance. Examples 6 and 8 are abiotic experiments in which the product benzoic acid (Example 6) or lactic acid (Example 8) is added to the reaction mixture to simulate its production in a fermentation process. This demonstrates this effect by matching the applied current to the addition rate of benzoic acid or lactic acid, and indicates that the product (benzoic acid or lactic acid) migration rate is linearly dependent on the applied current density.
- A general advantage of electrochemical processes is therefore that automatic control can be readily effected, since it is possible to control the reaction rate by adjustment of the applied current. An aspect of this invention is the development of automatic pH control of biotransformation reaction mixtures, as part of continuous product recovery by modified electrodialysis.
- A useful, novel aspect of the present invention concerns the combination of the bio-reactor with the electro-membrane separation/concentration into a single integrated system, since the advantages of both the DC enhancement effect reaction rate and the improved electrodialysis product recovery system can be realised. The bio-reactor can be situated within an electrodialysis cell (as shown in
FIG. 2 ) or the biomass can be contained mainly in a separate bio-reactor and re-circulated to an electrodialysis stack (as shown inFIG. 3 ). The current literature on the integration of electrodialysis processes with biocatalysis does not describe any interaction between the electric field and the biological material. - The improvements across the electrodialysis process, enabled by aspects of this invention, will provide more efficient, continuous operation of biocatalysis reactions. The solutions offered by the invention advantageously will allow bipolar electrodialysis to be applied to continuous extraction of ionic organic products from live biocatalysis reaction mixtures thus preventing competitive anion transfer resulting in the substantial increase in the current efficiency of the product separation process. In addition, the invention will enable control of the pH within the narrow optimal range essential for efficient operation of each specific biocatalysis reaction. Manual adjustment of the current supply has been suggested by prior workers as a method of controlling pH in lactic acid production by fermentation (9). However, imbalances in the system due to the transport of inorganic components in the fermentation broth were not taken into account. The improvements proposed will allow precise continuous control of pH. This may be achieved automatically by computer-controlled feedback loop to adjust the level of applied DC current and will obviate the need for pH control by chemical additions. Furthermore, the product concentrations will be maintained at low levels in the biocatalysis reaction mixtures, thus greatly reducing any negative feedback inhibition of catalyst activity. In addition to enabling continuous operation, the approach will also achieve substantial improvements in the efficiency of product isolation and concentration from batch processes.
- The improvements in product separation/concentration offered by the invention can be applied to a broad spectrum of biocatalysis processes which involve the production of acidic organic compounds which are dissociated into negatively charged anions within the pH range necessary for high enzymatic activity. The approach has been applied to two specific reactions as set out more fully below, which are examples of two generic reaction types. Firstly, a whole cell single enzyme biotransformation, i.e., the conversion of benzonitrile to benzoic acid by Rhodococcus rhodochrous LL100-21. Secondly, a whole cell multi-enzyme step fermentation, i.e., lactic acid production from glucose by Lactobacillus rhamnosus NCIMB 6375.
- The specific arrangements of the membranes according to the preferred aspects of the invention are provided in
FIGS. 2 to 4 . The bio-reaction mixture is contained between an anion-selective membrane on the anode-facing side and a bipolar membrane on the cathode facing side. When a standard buffer containing anionic components (e.g., borate) is present in the biocatalysis reaction mixture, competition is observed between the transport of the buffer anion and the organic acid anion. Even when small concentrations of anionic buffer are included, the current efficiency for product transfer is relatively low, e.g., the average current efficiency for benzoate transport is only 50% in the presence of 0.045 M boric acid. Because of this process inefficiency, substantially higher energy is consumed in achieving the desired rate of removal of the organic product. However, when a cationic buffer system (e.g., bis-Tris) is incorporated into the reaction mixture, so that there are no anions present other than the organic product, the applied current was fully utilised in the transport of organic product through the membrane. In Example 7 a current efficiency of 75% was observed. The example is an abiotic experiment in which the addition of benzoic acid to the reaction mixture simulates its production during a fermentation process. TRIS buffer was used for the simulated bio-reaction stream. The competitive charge transport by migration of hydroxide produced at the bipolar membrane decreases the current efficiency, however, this can be reduced by higher organic product concentrations. The low solubility of benzoic acid in water prevents its use for an example to prove this point. In Example 8, the current efficiency observed was close to 100%, significantly reducing the energy consumption and also increasing the rate of product separation. The example is an abiotic experiment in which the addition of lactic acid to the reaction mixture simulates its production during a fermentation process. Also, the presence of the bipolar membrane prevents the transport of the cationic buffer (bis-Tris in this case) towards the cathode, so that the buffer is retained within the bio-reaction mixture. As a result, the pH can be closely maintained without the consumption of expensive chemicals. - A common problem encountered when using membrane systems with microorganisms is membrane fouling. Regular membrane cleaning cycles can be introduced to the process to maintain the efficiency of the membrane operation (9).
- However, the present invention has solved this problem by the immobilisation of microorganisms used which advantageously prevents fouling of membranes. The present inventors have found that membrane fouling is therefore either prevented or at least greatly reduced by using immobilised microorganisms, for example yeasts or bacteria. This effect was observed during the experiment given in Example 4, where the immobilisation medium was incorporated into a combined bio/electrodialysis reactor in order to benefit from the effects of both the DC field enhancement and reduced membrane fouling.
- However, the volume of the electrodialysis stack reactor required to carry out this procedure in a combined bio/electrodialysis reactor would be very large. An alternative approach may be to contain the immobilisation media incorporating the microorganisms in a separate bioreactor of a standard design (continuously stirred, fluidised bed, packed bed, etc.). However, no DC enhancement effect would be obtained in that case, since the microorganisms would not be exposed to the field. Therefore, a second DC field would be required, which may be applied to the bioreactor containing the immobilised microorganism, in order to obtain the DC enhancement effect in addition to product recovery/concentration. The second system would incorporate two bipolar membranes either side of the reactor to enable the field effects to be achieved without separation (as in Example 3). A relatively small area of bipolar membrane would be necessary in the bio-reactor to achieve the enhancement effect, while the relatively high membrane area required for product separation would be provided in a separate membrane stack.
- The biocatalysis reaction according to the invention may comprise any of a single enzyme biotransformation reaction, a fermentation process, or a reaction catalysed by an isolated enzyme system. The reactions may be carried out with the assistance of growing microbial cultures, vesting microbial cultures or immobilised cultures of bacteria, fungi, or yeasts.
- The present invention will now be described by reference to the following examples and accompanying drawings.
-
FIG. 1 is an illustration of a glass reactor consisting of a round-bottomed glass vessel with flanged lid. The Bio-Reaction Chamber (3) includes a spherical reaction vessel with total capacity of 250 ml. The Anode (1) and the Cathode (2) are housed in glass tubes, inserted through the flanged lid and contained in inert electrolyte. The electrodes are made of platinised titanium, with a rectangular surface of 2 cm×1.5 cm. The tubes are immersed in the biotransformation reaction mixture contained within the flask. The reaction mixture is separated from the anode and cathode compartments by Porous Glass Windows (4). The separators allow the passage of current, but prevent the biomass from contacting the electrodes. No product separation was involved. -
FIG. 2 is an illustration of a combined Bio-/Electro-Membrane Reaction used in the present invention. - This reactor design enables the Bio-reactor chamber to be integrated within a modified electrodialysis stack containing ion selective and biopolar membranes, so that the effects of biotransformation reaction rate enhancement and product separation can be combined.
- The reactor contains a Bio-Reaction Chamber (3) made of Perspex with a 1.4 L working capacity, containing the entire volume of the biotransformation reaction mixture. A magnetic stirrer continuously mixes the medium containing the cell mass in the central chamber, but there is no circulation of this mixture to an external vessel. Bolted onto one side are two further chambers and the Anode (1) (platinised titanium). An Anion Selective Membrane (5) (Neosepta ACM) is situated between the Bio-Reaction Chamber and the Product Concentrate Chamber (8). The product chamber is separated from the Anolyte Chamber (9) by a cation selective membrane (7) (DuPont Nafion 450). Bolted on the other side of the Bio-Reaction Chamber are the Catholyte Chamber (10) and the Cathode (2) (stainless steel). A Bipolar Membrane (6) (Tokuyama Co. Ltd. BPM 1) separates the Bio-Reaction Chamber and the catholyte chamber. Chambers (8), (9) and (10) are much thinner than chamber (3) and are fitted with inlets and outlets to enable the solutions to be circulated to separate external reservoirs at the speed of 20 ml/min. The electrodes of the reactor have a rectangular surface of 10 cm×10 cm.
-
FIG. 3 is an illustration of an Electro-Membrane Stack Reactor used in accordance with the present invention. - The reactor design enables a generic, industrial electro-membrane stack system to be used for the enhancement of bio-transformation reaction rate and separation of product. The reaction mixture, containing biomass, is re-circulated from a separate bio-reactor, through the Bio-Reaction Chamber of the membrane stack reactor.
- The stack contains four chambers fabricated from HDPE with
dimensions 3 mm×160 mm×230 mm. The active area of each membrane exposed by the frames was 120 mm×160 mm. A polymer mesh (HDPE) is provided in each frame to provide membrane support and good hydrodynamic flow. The Bio-Reaction Chamber dimensions are identical to the other chambers. All solutions are re-circulated to external vessels. In the case of the reaction mixture, the biomass is in suspension and therefore passes through the electro-membrane stack and is exposed to the DC field for part of the time. - The two end plates incorporate recessed electrodes. The anode (tantalum/iridium oxide coated titanium) is in contact with a bead of Silicone Sealant which fills an annular groove machined in the electrode recess PVC plate. The cathode (titanium) is similarly sealed into the PVC support plate. The electrodes have a rectangular surface of 120 mm×160 mm.
- The arrangement of electrodes and membranes is identical to that described in the Combined Bio-/Electro-Membrane Reactor (component numbering is the same).
-
FIG. 4 is an illustration of Membrane Arrangements used in Single and Multiple Unit Stacks. - The arrangement of membranes used in the Electro-Membrane Stack Reactor is given in
FIG. 4 . InFIG. 4( a) the system contains a single unit of one bipolar membrane and one anion selective membrane, with a single cation selective membrane adjacent to the anolyte compartment.FIG. 4( b) illustrates the arrangement used in a multiple unit cell for industrial application. - This example demonstrates that the biotransformation enhancement effect is observed in a simple glass reactor, in which the bio-reaction mixture is prevented from contacting the electrodes by the inclusion of porous separators.
- Starter cultures of Rhodococcus rhodococcus (LL100-21) were grown at 30° C. in 50 ml of a liquid medium in an orbital shaker (160 rpm) until the late exponential phase of growth. The medium contained: TRIS Borate Buffer (0.045 M H3BO3, 0.33 M TRIS—Tris-(hydroxymethyl)aminomethane) (TBB), 0.5 mM KH2PO4, 8.6 mM NaCl, 0.01 M CaCl2, 0.1 M MgSO4 and 1 ml/L of trace elements (Beauchop, 1960). During the reaction, benzonitrile provided the sole source of carbon and nitrogen. To produce cells for biotransformation a 4% w/v inoculum of starter cells was used in a final volume of 500 ml and the culture was grown aerobically at 30° C. in an orbital shaker (160 rpm) for 36 hours. Cells were finally harvested in early/mid-exponential phase of growth by centrifugation for 15 min at 13000 g. The cells were washed in TBB three times and then re-suspended in 200 ml TBB into the Glass Cell Reactor. Each Electrode chamber contained 15 ml TBB. Bacteria were placed directly into M and 10 mM benzonitrile was added. A current of 16.6 A/m2 DC was applied for a period of 260 minutes. In the presence of the constant electric current the average production rate was 0.027 mmol/min/g dcw (dry cell weight).
- The experiment was repeated under the same conditions without applying a constant electric current to the cells in the glass cell reactor. The average production rate in the absence of electric current was 0.020 mmol/min/g dcw.
- This example shows that electric current increases the biotransformation rate by 35%.
- This example demonstrates that the biotransformation enhancement effect is observed in the combined Bio-Electro-Membrane Reactor, and that product separation/concentration can be achieved simultaneously. Starter cultures of bacteria (50 ml) were prepared as described in Example 1. A 4% w/v inoculum of starter cells was used in a final volume of 500 ml and the culture was grown at 30° C. for 36 hours. Cells were finally harvested in mid/late-exponential phase of growth by centrifugation for 15 min at 13000 g. The cells were washed in TBB three times and then re-suspended in 1.4 L TBB into the Combined Bio-/Electro-Membrane Reactor. The pH of the product concentrate was maintained at
pH 8 through addition of 4 N NaOH by means of a pH control system comprising a DIN rail mounted pH controller, a variable pump, and a pH electrode. 500 ml of TBB was used as electrolyte for chambers (8), (9), and (10). - 10 mM benzonitrile was added to the reaction mixture to initiate the biotransformation. DC current was switched on and set to deliver a constant current of 16.6 A/m2. In the presence of the constant electric current the average production rate was 0.044 mmol/min/g dcw. Benzoic acid migrated into the Product Concentrate Chamber with a migration rate of 0.02 mmol/min.
- The experiment was repeated under the same conditions without applying a constant electric current to the cells in the electrokinetic reactor. The average production rate in the absence of electric current was 0.031 mmol/min/g dcw.
- This example shows that electric current increases the biotransformation rate by 42% and that concentrated benzoic acid can be recovered by electrodialysis.
- This experiment was conducted in order to demonstrate that the biotransformation enhancement effect did not result from the product separation/concentration process, by replacing the anion selective membrane with a bipolar membrane in the Combined Bio-Electro-Membrane Reactor. The cell mass of Rhodococcus rhodococcus LL100-21 was grown and harvested in the same way as in Example 2. The cells were re-suspended in 1.4 L TBB and added to the Combined Bio-/Electro-Membrane Reactor. However, this reactor was modified by replacing the anion selective membrane (used in Example 2) between the Bio-Reaction Chamber and the Product Concentrate Chamber by a bipolar membrane (Tokuyama Neosepta BP-1), therefore no benzoic acid product was transported out of the reaction mixture. 10 mM of benzonitrile was added to the cells and DC current was switched on (16.6 A/m2). In the presence of the constant electric current the average production rate was 0.023 mmol/min/g dcw. The experiment was repeated under the same conditions without applying a constant electric current to the cells in the reactor. The average production rate in the absence of electric current was 0.018 mmol/min/g dcw. This example shows that electric current stimulates bacterial metabolism increasing the biotransformation rate by 28%.
- This example demonstrates that the biotransformation enhancement effect is observed using immobilised biomass in the combined Bio-Electro-Membrane Reactor, and that product separation/concentration can be achieved simultaneously. Starter cultures of bacteria (50 ml) were prepared as described in Example 1. A 4% w/v inoculum of starter cells was used in a final volume of 500 ml and the culture was grown at 30° C. Once bacterial cultures had reached the late exponential phase of growth they were harvested by centrifugation at 13000 g for 15 min. The supernatant was discarded and bacteria were re-suspended in TBB to a final density of 5 g/L. The cell concentrate was then mixed with an equal volume of 4% alginate. The dense suspension was added drop-wise through a hypodermic needle into 1 L of 0.25 M CaCl2 in order to allow the solidification of the alginate into regular spheres. These alginate beads containing the bacteria were harvested by use of a sieve, washed once with TBB and suspended in 1.4 L TBB in the Bio-Reaction Chamber of the Combined Bio-/Electro-Membrane Reactor illustrated in
FIG. 2 , using the standard membrane arrangement, as in Example 2. 10 mM of benzonitrile was added to the cells and DC current was switched on (16.6 A/m2). In the presence of the constant electric current the average production rate was 0.042 mmol/min/g dcw. Benzoic acid migrated into the Product Concentrate Chamber MA with a migration rate of 0.02 mmol/min. The experiment was repeated under the same conditions without applying a constant electric current to the cells in the reactor. The average production rate in the absence of electric current was 0.032 mmol/min/g dcw. This example shows that electric current increases the biotransformation rate of the immobilised microorganisms by 31%. - This example is included to demonstrate that the biotransformation enhancement effect is observed in the Electro-Membrane Stack Reactor, in spite of the fact that the biomass is exposed to the influence of the applied DC field for part of the reaction time only, due to circulation from an external bioreactor. Starter cultures of bacteria (50 ml) were prepared as described in Example 1. A 4% w/v inoculum of starter cells was used in a final volume of 500 ml and the culture was grown at 30° C. for 36 hours. Cells were finally harvested in mid/late-exponential phase of growth by centrifugation for 15 min at 13000 g. The cells were washed in TBB three times and then re-suspended in 0.5 L TBB and transferred into a glass flask fermenter of 0.6 L in capacity, which was aseptically connected to the Bio-Reaction Chamber of the Electro-Membrane Stack Reactor. 500 ml of TBB was used as electrolyte for the Anolyte, Catholyte and Product Concentrate Chambers. The pH of the Product Concentrate Chamber was maintained at
pH 8 by means of a pH control system described in Example 2. 10 mM of benzonitrile was added to the cells and biotransformation was carried out by Rhodococcus rhodococcus LL100-21 in the absence of electric current in the reactor for 210 minutes. The biotransformation rate was 0.030 mmol/min/g dcw. After 210min 10 mM of benzonitrile was added again and DC current was switched on (16.6 A/m2). In the presence of the constant electric current the average production rate was 0.044 mmol/min/g dcw. Benzoic acid migrated into the Product Concentrate Chamber with a migration rate of 0.02 mmol/min. This example shows that electric current increases the biotransformation rate by 47% and that concurrent separation and concentration of benzoic acid can be achieved with this electro-membrane stack. - This example, in which the Electro-Membrane Stack Reactor was operated in abiotic mode, demonstrates that pH can be precisely controlled by the variation of applied current. One litre of TBB was circulated through each the Anolyte and Catholyte Chamber and one litre of TBB containing 11 mmol benzoic acid was circulated through the Product Concentrate Chamber. One litre of TBB containing 5 mmol benzoic acid was circulated through the Bio-reaction chamber. DC current was supplied to the electrodialysis stack. A concentrated solution of benzoic acid was added continuously to the solution circulated through the Bio-Reaction Chamber with varying addition rates. The current to be applied was changed manually according to the benzoic acid addition rate to maintain the pH in the Bio-reaction chamber at 8. Benzoic acid was first added with an addition rate of 0.025 mmol/min. The supplied current was 0.09 A. After 4½ hours the addition rate was decreased to 0.012 mmol/min and the current was changed to 0.04 A. Half an hour afterwards benzoic acid was added with a rate of 0.041 mmol/min and the current was changed to 0.15 A. After 5½ hours operation 20 mmol of benzoic acid (82% of the total benzoic acid) were recovered in the Product Concentrate stream. 4 mmol of benzoic acid remained in the Bio-Reaction stream (16% of the total benzoic acid). The average current efficiency was 50%. During the experiment the pH in the Bio-Reaction stream stayed between 8.0 and 8.1.
- This example shows that the pH in the reaction mixture can be controlled by adjustment of the applied current and that the migration rate of the product (benzoic acid in this case) is linearly dependent on the applied current density.
- This example, in which the Electro-Membrane Stack Reactor was operated in abiotic mode, demonstrates that higher current efficiencies can be achieved by avoiding other anions than the product (benzoate in this case) in the Bio-reaction stream and that pH stability can be obtained, due to the presence of TRIS buffer, Tris-(hydroxymethyl)aminomethane. A half litre of a 0.1 M Na2SO4 solution was circulated through each the Anolyte and Catholyte Chambers. A half litre of TBB was circulated through the Product Concentrate Chamber. A half litre of a 0.5 M Trizma base solution containing 5 mmol benzoic acid was circulated through the Bio-reaction chamber. DC current (0.15 A) was supplied to the electrodialysis stack. A concentrated solution of benzoic acid was added continuously to the solution circulated through the Bio-Reaction Chamber with an addition rate of 0.07 mmol/min. After 5½ hours operation 22 mmol of benzoic acid (78% of the total benzoic acid) were recovered in the Product Concentrate stream. 6 mmol of lactic acid remained in the Bio-Reaction stream (21% of the total benzoic acid). The average current efficiency was 75%.
- During the experiment the pH in the Bio-Reaction stream stayed between 8.3 and 8.4. This example shows that avoiding other anions than the product (benzoate in this case) in the bio-reaction stream increases the current efficiency. At the same time, because of the use of TRIS buffer, the pH remains stable in the biotransformation reaction medium.
- This example, in which the Electro-Membrane Stack Reactor was operated in abiotic mode, demonstrates that high current efficiencies can be achieved for product separation/concentration and that pH stability can be obtained, due to the presence of cationic buffer. It also demonstrates that higher current efficiencies can be achieved by higher product concentrations, which minimise competitive charge transport by hydroxide migration. Lactic acid was used as a model product instead of benzoic acid, because the low solubility of benzoic acid in water prevents its use in higher concentrations. One litre of 0.1 M sulphuric acid was circulated through the Anolyte and the Catholyte Chambers, and 1.1 litre of a 1.6 M lactic acid solution was circulated through the Product Concentrate Chamber. A solution (0.5 litre) of 0.05 M bis-Tris buffer containing 0.1 mol lactic acid was circulated through the Bio-Reaction Chamber. DC current was supplied to the stack. Lactic acid (85%) was added continuously to the solution circulated through the Bio-Reaction Chamber with varying addition rates. The current to be applied was changed manually according to the lactic acid addition rate to maintain the pH at 6. Lactic acid was first added with an addition rate of 2.4 mmol/min for 4 hours. The supplied current was 3.5 A. After 4 hours the addition rate was increased to 3.6 mmol/min and the current was changed to 5.2 A. 1½ hours afterwards lactic acid was added with a rate of 4.8 mmol/min and the current was changed to 6.9 A. After 6½ hours operation 2.95 mol of lactic acid (97% of the total lactic acid) were recovered in the Product Concentrate stream. 0.03 mol of lactic acid remained in the bio-reaction stream (1% of the total lactic acid). The average current efficiency was 100%. During the experiment the pH in the simulated reaction mixture was successfully maintained between 5.9 and 6.3. This example shows that the product (lactic acid) can be recovered with this electro-membrane stack design and that the use of a cationic buffer and higher product concentration (lactic acid in this case) in the Bio-Reaction stream increases the current efficiency.
- Therefore, novel effects of the invention have been demonstrated in a laboratory glass reactor, given in
FIG. 1 . The experimental details and results of which are given in Example 1. This example demonstrated that the application of a DC electric field increased the biotransformation rate by 35%. - The novel effect has also been reproduced in a laboratory-scale modular laboratory reactor design, given in
FIG. 2 . This type of electro-membrane electrochemical reactor design is a suitable model design for scale-up to industrial-scale. The experimental details are given in Examples 2, 3, and 4. - In Example 2, the product (benzoic acid) was also transferred continuously from the biotransformation reaction mixture by the DC field through an anion selective membrane into a product stream. In Example 3, the anion membrane was replaced by a bipoloar membrane, so that no transfer of product was possible. In Example 4, separation of product (as carried out in Example 2) was combined with immobilisation of the bacterial cells on alginate beads. These examples demonstrated that the application of a DC electric field increased the biotransformation rates in Examples 2, 3, and 4 by 42%, 28%, and 31% respectively.
- The novel effect has also been reproduced in a laboratory-scale electro-membrane stack, given in
FIG. 3 . The design of this reactor was suitable for direct scale-up to industrial plant. The experimental details are given in Example 5. The system was operated with continuous separation of benzoic acid using an anion exchange membrane. In this example, the DC field enhanced the biotransformation rate by 47%. In this case, the bacteria were recycled from an external reservoir through the electrodialysis stack. Therefore, the result confirms that the enhancement effect can be maintained when the electrochemical reactor is situated outside the main bioreactor. - Unlike electroporation, which employs AC fields, the new effect is achieved through the application of DC fields. Also, prior work on increased cell growth and metabolite production has involved pulsed electromagnetically induced AC currents.
- 1) S. Velizarov; Electro- and Magnetobiology, 18(2), 185-212 (1999).
- 2) A. McCabe, N. Barron, L. McHale and A. P. McHale; Biotechnol. Tech. 9, 133-136 (1995).
- 3) P. Yong, J. P. G. Farr, I. R. Harris and L. Macaskie; Biotechnology Letters 24, 205-212 (2002).
- 4) I. Hones, A. Pospischil, H. Berg; Bioelectrochemistry and Bioenergetics 44, 275-277 (1998).
- 5) F. Miao; U.S. Pat. No. 5,681,728 (Oct. 28, 1997).
- 6) R. Cabacang, M. Kishimoto, K. Suga; Biotechnology for Sustainable Utilisation of Biological Resources in the Tropics 14, 226-235 (2000).
- 7) J. D. Genders, R. Gopal, D. M. Hartsough, P. M. Kendall, W. J. Long, D. J. Mazur, G. D. Zappi; U.S. Pat. No. 6,187,570 (Feb. 13, 2001).
- 8) O. Favre-Bulle, J. Pierrard, C. David, P. Morel, D. Horbez; U.S. Pat. No. 6,180,359 (Jan. 30, 2001).
- 9) Y. Nomura, M. Iwahara and M. Hongo; Biotechnology and Bioengineering 30, 788-793 (1987).
- While the foregoing is directed to embodiments of the present invention, other and further embodiments of the invention may be devised without departing from the basic scope thereof, and the scope thereof is determined by the claims that follow.
Claims (17)
1. A process for increasing a rate of a biocatalysis reaction, which comprises:
applying a direct current (DC) electric field to a reaction mixture, wherein the reaction mixture includes an ionic buffer, and electrodes used to apply said electric field are separated from the reaction mixture by a separation membrane of a polarity to prevent transport of the ionic buffer and such that the reaction mixture does not come into contact with said electrodes.
2. A process according to claim 1 , wherein said electric field is applied for a sufficient time to stimulate the biocatalysis reaction in the reaction mixture.
3. A process according to claim 1 , wherein said separation membrane is a bipolar ion exchange membrane.
4. A process according to claim 1 , wherein said electrodes form part of an electrochemical reactor.
5. A process according to claim 4 , wherein said electrochemical reactor forms part of an electrodialysis stack, wherein charged organic products in the reaction mixture can be removed by electrodialysis.
6. A process according to claim 1 , wherein said reaction mixture is contained between the bipolar ion exchange membrane on a cathode-facing side and an anion selective membrane on an anode-facing side of said reaction mixture.
7. A process according to claim 1 , wherein the ionic buffer comprises a cationic buffer, with an organic product forming an anionic component.
8. A process according to claim 7 , wherein the DC electric field applied is adjusted to control pH of the reaction mixture.
9. A process according to claim 8 , wherein adjustment to the DC electric field is automatically controlled under control of a computer program.
10. A process according to claim 1 , wherein the biocatalysis reaction is selected from a single enzyme biotransformation reaction, a fermentation process and a reaction catalyzed by an isolated enzyme system.
11. A process according to claim 1 , wherein the reaction mixture comprises any of growing or resting microbial cultures.
12. A process according to claim 11 , wherein said microbial cultures comprise immobilized cultures of yeast, bacteria or fungi.
13. A process according to claim 12 , wherein said microbial cultures are immobilized on surfaces or in pores of beads.
14. A process according to claim 6 , wherein the ionic buffer comprises a cationic buffer, with an organic product forming an anionic component.
15. A process according to claim 6 , wherein the reaction mixture comprises immobilized microbial cultures of yeast, bacteria or fungi.
16. A process according to claim 6 , wherein the reaction mixture comprises immobilized microbial cultures on surfaces or in pores of beads.
17. A process according to claim 7 , wherein the reaction mixture comprises immobilized microbial cultures of yeast, bacteria or fungi on surfaces or in pores of beads.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/414,506 US20090178932A1 (en) | 2002-11-19 | 2009-03-30 | Control of biocatalysis reactions |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0227021A GB2395481B (en) | 2002-11-19 | 2002-11-19 | Control of biocatalysis reactions |
GB0227021.3 | 2002-11-19 | ||
US10/535,687 US20060141555A1 (en) | 2002-11-19 | 2003-11-19 | Control of biocatalysis reactions |
PCT/GB2003/005031 WO2004046351A1 (en) | 2002-11-19 | 2003-11-19 | Control of biocatalysis reactions |
US12/414,506 US20090178932A1 (en) | 2002-11-19 | 2009-03-30 | Control of biocatalysis reactions |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2003/005031 Continuation WO2004046351A1 (en) | 2002-11-19 | 2003-11-19 | Control of biocatalysis reactions |
US10/535,687 Continuation US20060141555A1 (en) | 2002-11-19 | 2003-11-19 | Control of biocatalysis reactions |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090178932A1 true US20090178932A1 (en) | 2009-07-16 |
Family
ID=9948150
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/535,687 Abandoned US20060141555A1 (en) | 2002-11-19 | 2003-11-19 | Control of biocatalysis reactions |
US12/414,506 Abandoned US20090178932A1 (en) | 2002-11-19 | 2009-03-30 | Control of biocatalysis reactions |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/535,687 Abandoned US20060141555A1 (en) | 2002-11-19 | 2003-11-19 | Control of biocatalysis reactions |
Country Status (6)
Country | Link |
---|---|
US (2) | US20060141555A1 (en) |
EP (1) | EP1565556A1 (en) |
JP (1) | JP2006506085A (en) |
AU (1) | AU2003302128A1 (en) |
GB (1) | GB2395481B (en) |
WO (1) | WO2004046351A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1632568A1 (en) * | 2004-09-03 | 2006-03-08 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Process and apparatus for the production and separation of fermentation products |
EP1968470B1 (en) * | 2006-01-03 | 2010-05-05 | Alcon, Inc. | System for dissociation and removal of proteinaceous tissue |
GB0704025D0 (en) * | 2007-03-02 | 2007-04-11 | Ekb Technology Ltd | Inhibitory product removal |
US9249431B2 (en) | 2008-02-28 | 2016-02-02 | Green Biologics Limited | Production process |
US20110118729A1 (en) * | 2009-11-13 | 2011-05-19 | Alcon Research, Ltd | High-intensity pulsed electric field vitrectomy apparatus with load detection |
US20110118734A1 (en) * | 2009-11-16 | 2011-05-19 | Alcon Research, Ltd. | Capsularhexis device using pulsed electric fields |
US20110135626A1 (en) * | 2009-12-08 | 2011-06-09 | Alcon Research, Ltd. | Localized Chemical Lysis of Ocular Tissue |
US20110144562A1 (en) * | 2009-12-14 | 2011-06-16 | Alcon Research, Ltd. | Localized Pharmacological Treatment of Ocular Tissue Using High-Intensity Pulsed Electrical Fields |
US8546979B2 (en) | 2010-08-11 | 2013-10-01 | Alcon Research, Ltd. | Self-matching pulse generator with adjustable pulse width and pulse frequency |
CN104254390B (en) * | 2012-02-15 | 2017-05-10 | 生物辐射实验室股份有限公司 | electronic control of pH and ionic strength |
CN105964145B (en) * | 2016-06-17 | 2019-01-22 | 中国科学技术大学 | A kind of method that bipolar membrane electrodialysis produces water-insoluble organic acid |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336387A (en) * | 1990-09-11 | 1994-08-09 | Bioseparations, Inc. | Electrical separator apparatus and method of counterflow gradient focusing |
US6110342A (en) * | 1998-07-21 | 2000-08-29 | Archer Daniels Midland Company | Process for production of amino acid hydrochloride and caustic via electrodialysis water splitting |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH490305A (en) * | 1967-03-28 | 1970-05-15 | Politechnika Slaska Im Wincent | Manufacturing process of carboxylic acids |
JPS62146595A (en) * | 1985-12-20 | 1987-06-30 | Daicel Chem Ind Ltd | Continuous production of organic acid by fermentation |
JPS63188385A (en) * | 1987-01-29 | 1988-08-03 | Shimadzu Corp | Film type bioreactor |
FR2614038B1 (en) * | 1987-04-17 | 1989-08-04 | Centre Nat Rech Scient | ELECTROENZYMATIC PROCESS FOR THE PRODUCTION OF ENANTIOMERIC CONTROLLED PURITY COMPOUNDS |
US4890199A (en) * | 1988-11-04 | 1989-12-26 | Motorola, Inc. | Miniature shield with opposing cantilever spring fingers |
FR2673041A1 (en) * | 1991-02-19 | 1992-08-21 | Gemplus Card Int | METHOD FOR MANUFACTURING INTEGRATED CIRCUIT MICROMODULES AND CORRESPONDING MICROMODULE. |
US6611054B1 (en) * | 1993-12-22 | 2003-08-26 | Honeywell Inc. | IC package lid for dose enhancement protection |
US6242690B1 (en) * | 1995-09-25 | 2001-06-05 | Ericsson Inc. | Gasket system for EMI isolation |
DE19709042A1 (en) * | 1997-03-06 | 1998-09-10 | Alsthom Cge Alcatel | Housing for micro-optical and / or micro-electrical components |
JPH11307974A (en) * | 1998-04-27 | 1999-11-05 | Sony Corp | Apparatus and method for electromagnetic shield |
JP3739230B2 (en) * | 1999-04-26 | 2006-01-25 | 株式会社日立製作所 | High frequency communication equipment |
-
2002
- 2002-11-19 GB GB0227021A patent/GB2395481B/en not_active Expired - Fee Related
-
2003
- 2003-11-19 EP EP03811433A patent/EP1565556A1/en not_active Withdrawn
- 2003-11-19 US US10/535,687 patent/US20060141555A1/en not_active Abandoned
- 2003-11-19 WO PCT/GB2003/005031 patent/WO2004046351A1/en active Application Filing
- 2003-11-19 AU AU2003302128A patent/AU2003302128A1/en not_active Abandoned
- 2003-11-19 JP JP2004552895A patent/JP2006506085A/en active Pending
-
2009
- 2009-03-30 US US12/414,506 patent/US20090178932A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336387A (en) * | 1990-09-11 | 1994-08-09 | Bioseparations, Inc. | Electrical separator apparatus and method of counterflow gradient focusing |
US6110342A (en) * | 1998-07-21 | 2000-08-29 | Archer Daniels Midland Company | Process for production of amino acid hydrochloride and caustic via electrodialysis water splitting |
Also Published As
Publication number | Publication date |
---|---|
GB2395481B (en) | 2006-06-28 |
EP1565556A1 (en) | 2005-08-24 |
GB0227021D0 (en) | 2002-12-24 |
JP2006506085A (en) | 2006-02-23 |
AU2003302128A1 (en) | 2004-06-15 |
US20060141555A1 (en) | 2006-06-29 |
GB2395481A (en) | 2004-05-26 |
WO2004046351A1 (en) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090178932A1 (en) | Control of biocatalysis reactions | |
Li et al. | An electrokinetic bioreactor: using direct electric current for enhanced lactic acid fermentation and product recovery | |
US10883121B2 (en) | Processes for fermentation and purification of value added products from gaseous substrates | |
EP3502063A1 (en) | Continuous method for reducing the amount of organic compounds in wastewater | |
Velizarov | Electric and magnetic fields in microbial biotechnology: possibilities, limitations, and perspectives | |
Luetz et al. | Membranes in biotechnology | |
Abbott | Immobilized cells | |
Xuemei et al. | L-lactic acid production using immobilized Rhizopus oryzae in a three-phase fluidized-bed with simultaneous product separation by electrodialysis | |
EP2349541B1 (en) | Process for controlling the ph and level of target ions of a liquid composition | |
CN109371070A (en) | A kind of method of high yield α-ketoisovaleric acid | |
Devaux‐Basséguy et al. | Electroenzymatic processes: a clean technology alternative for highly selective synthesis? | |
Mesa et al. | Biological iron oxidation by Acidithiobacillus ferrooxidans in a packed-bed bioreactor | |
JP2006506085A5 (en) | ||
JP2009060876A (en) | Method for producing hydrogen and device for producing hydrogen | |
JP5027462B2 (en) | Method for culturing photosynthetic microorganisms | |
Choudhury et al. | Lactic acid fermentation in cell-recycle membrane bioreactor | |
HÄggström et al. | Continuous production of butanol with immobilized cells of Clostridium acetobutylicum | |
Mustacchi et al. | Enhanced biotransformations and product recovery in a membrane bioreactor through application of a direct electric current | |
JP3777534B2 (en) | Bacterial electroculture method in anaerobic environment | |
US20130081947A1 (en) | Bioprocess utilizing carbon dioxide and electrodeionization | |
Mustacchi et al. | The effect of whole cell immobilisation on the biotransformation of benzonitrile and the use of direct electric current for enhanced product removal | |
EP3592836B1 (en) | Process for the bioreactive extraction of produced oxygen from a reaction chamber, and use of phototrophic micro-organisms in the recovery of hydrogen | |
Hekmat et al. | Production of pyruvate from (R)-lactate in an enzyme–membrane reactor with coupled electrochemical regeneration of the artificial mediator anthraquinone-2, 6-disulfonate | |
Powell | Immobilized biocatalyst technology | |
JPH11137286A (en) | Fermentation of lactic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |